We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M Turnover 17.24%
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
+27.59%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$592M
AUM Growth
+$78.5M
Cap. Flow
+$48.3M
Cap. Flow %
8.16%
Top 10 Hldgs %
62.58%
Holding
88
New
16
Increased
4
Reduced
1
Closed
7
Avg Time Held
0.8 years
Top 10 Avg Time Held
0.8 years
Top 20 Avg Time Held
0.9 years

Top Buys

Rank Stock Value
1
FNCH icon
Finch Therapeutics Group, Inc. Common Stock
FNCH
+$13.8M
2
ISLE
Isleworth Healthcare Acquisition Corporation Common stock
ISLE
+$9.66M
3
FLNA icon
Filana Therapeutics
FLNA
+$8.48M
4
CNST
Constellation Pharmaceuticals, Inc.
CNST
+$5.53M
5
GBT
Global Blood Therapeutics, Inc.
GBT
+$4.6M

Top Sells

Rank Stock Value
1
TGTX icon
TG Therapeutics
TGTX
+$3.9M
2
IDN icon
Intellicheck
IDN
+$2.99M
3
EOSEW icon
Eos Energy Enterprises Warrant
EOSEW
+$2.08M
4
HCARU
Healthcare Services Acquisition Corporation Unit
HCARU
+$1.53M
5
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
+$1.13M

Sector Composition

Rank Sector Weight
1 Healthcare 25.7%
2 Miscellaneous 14.31%
3 Industrials 13.57%
4 Consumer Discretionary 12.6%
5 Materials 9.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
LILA icon
76
Liberty Latin America Class A
LILA
$1.62B
$52K 0.01%
5,913
– –
2020 Q1
4 quarters
T icon
77
AT&T
T
$161B
$50K 0.01%
2,185
– –
2020 Q2
3 quarters
HCARW
78
DELISTED
Healthcare Services Acquisition Corporation Warrant
HCARW
$47K 0.01%
+75,000
New +$92.2K
2021 Q1
0 quarters
AJAX.WS
79
DELISTED
Capri Listco Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exer
AJAX.WS
$4K ﹤0.01%
+2,500
New +$7.37K
2021 Q1
0 quarters
ADEA icon
80
Adeia
ADEA
$2.4B
$2K ﹤0.01%
340
– –
2020 Q2
3 quarters
AVNW icon
81
Aviat Networks
AVNW
$250M
$2K ﹤0.01%
66
– –
2020 Q2
3 quarters
BLUE icon
82
DELISTED
bluebird bio
BLUE
– –
-1,930
Closed -$1.08M –
EOSEW icon
83
Eos Energy Enterprises Warrant
EOSEW
$14.2M
– –
-250,000
Closed -$2.08M –
TGTX icon
84
TG Therapeutics
TGTX
$8.57B
– –
-75,000
Closed -$3.9M –
XRX icon
85
Xerox
XRX
$352M
– –
-3,125
Closed -$72K –
ORTX
86
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
– –
-26,233
Closed -$1.13M –
HCARU
87
DELISTED
Healthcare Services Acquisition Corporation Unit
HCARU
– –
-150,000
Closed -$1.53M –
PRGX
88
DELISTED
PRGX Global, Inc.
PRGX
– –
-7,938
Closed -$61K –
1 2 3
4

Similar funds

NFW
Noble Family Wealth Clearwater, Florida $559M AUM 24.35% 1-Year Est. Return
SCM
Soros Capital Management New York $559M AUM 171.77% 1-Year Est. Return
PHC
Palidye Holdings (Caymans) Grand Cayman, Cayman Islands $559M AUM 1.08% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
BCM
Brasada Capital Management Houston, Texas $558M AUM 21.68% 1-Year Est. Return
FAM
Frontier Asset Management Sheridan, Wyoming $558M AUM 22.41% 1-Year Est. Return
WDG
Wealth Dimensions Group Cincinnati, Ohio $558M AUM 20.63% 1-Year Est. Return
OC
Opal Capital Boca Raton, Florida $560M AUM

Bleichroeder LP's Q1 2021 Portfolio in Review

As of Q1 2021, Bleichroeder LP held 88 positions worth $592M, up 15% from $514M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Bleichroeder LP deployed $48.3M of net new capital in Q1 2021, opening 16 new positions and adding to 4 existing holdings. Its largest new stake was Finch Therapeutics Group, Inc. Common Stock: 27,014 shares worth $13.1M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 22% a quarter earlier, followed by Miscellaneous and Industrials.

On the sell side, the largest reduction was Intellicheck, an estimated $2.99M trimmed.

  • Bleichroeder LP's largest Q1 2021 buy was Finch Therapeutics Group, Inc. Common Stock: 27,014 shares worth $13.1M.
  • Bleichroeder LP added most to Filana Therapeutics in Q1 2021, an estimated $8.48M increase.
  • Bleichroeder LP's biggest Q1 2021 reduction was Intellicheck, cutting an estimated $2.99M.
  • Bleichroeder LP fully exited TG Therapeutics in Q1 2021, selling an estimated $3.9M.
  • Bleichroeder LP's ten largest holdings make up 63% of its $592M portfolio in Q1 2021.
  • Bleichroeder LP opened 16 new positions and closed 7 in Q1 2021.
  • Bleichroeder LP's portfolio value rose 15% quarter-over-quarter to $592M.

Based on Bleichroeder LP's 13F filing for Q1 2021, filed 17 May 2021.